NBRAX
Price
$27.12
Change
-$0.10 (-0.37%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

NBRAX vs VMVAX

Header iconNBRAX vs VMVAX Comparison
Open Charts NBRAX vs VMVAXBanner chart's image
Neuberger Berman M/C Intrinsic Val A
Price$27.12
Change-$0.10 (-0.37%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NBRAX vs VMVAX Comparison Chart
Loading...
VS
NBRAX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBRAX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. NBRAX (56.4M). VMVAX pays higher dividends than NBRAX: VMVAX (2.14) vs NBRAX (0.40). NBRAX was incepted earlier than VMVAX: NBRAX (14 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. NBRAX (15.00). NBRAX has a lower initial minimum investment than VMVAX: NBRAX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. NBRAX (16.82). VMVAX return over 5 years is better than : 48.82 vs. NBRAX (35.79).
NBRAXVMVAXNBRAX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years13 years-
Gain YTD6.57814.94644%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets56.4M30.5B0%
Annual Yield % from dividends0.402.1419%
Returns for 1 year16.8225.3566%
Returns for 3 years15.7620.7176%
Returns for 5 years35.7948.8273%
Returns for 10 years15.06100.8815%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio